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Background:  The recruitment of immune cells to the site of inflammation plays a crucial role in the development and in the progression of 
atherosclerotic plaques. Extracellular adherence protein (Eap), which is an anti-inflammatory protein secreted by Staphylococcus aureus, was 
previously shown to inhibit ICAM-1-mediated interactions between leukocytes and lymphocytes with the vascular endothelium and to block leukocyte 
extravasation in various inflammatory disease models. We aimed here to investigate a possible influence of Eap on the development and progression 
of atherosclerotic lesions in ApoE-deficient mice.
methods:  Ten ApoE-/- mice (age 8 weeks, 25 g) were put on high fat diet for six weeks. Afterwards, five mice in the control group were 
intraperitoneally injected daily with 200 μL sterile phosphate buffered saline (PBS). In the treated group, five mice received a daily intraperitoneal 
injection of 50 µg Eap (strain Newman) in 200 µl sterile PBS. At day 28, mice were sacrificed and the aortic root was HE-stained and plaque size 
and plaque composition were determined.
results:  Mice treated with Eap showed significantly smaller atherosclerotic plaques than mice treated with PBS only. The total plaque area was 
0.66±0.35mm2 in the treated group as compared to 1.21±0.66mm2 in the control group (p<0.05). Furthermore, there was a robust difference 
in plaque composition between both groups: Plaques in control animals had larger necrotic cores and an increased number of inflammatory cells 
compared to mice treated with Eap.
conclusions:  We could show that Eap significantly reduced the size of atherosclerotic lesions in ApoE-/- mice. A reduction in the number of 
invading inflammatory cells in the lesion and smaller necrotic cores of the plaques were also observed in mice treated with Eap. Thus, Eap could 
present a therapeutic option to interfere with extravasation of inflammatory cells which is a key event in the pathogenesis of atherosclerosis.
